{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:21:04Z","timestamp":1793409664844,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,3]],"date-time":"2012-08-03T00:00:00Z","timestamp":1343952000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["All Asth Clin Immun"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1710-1492-8-14","type":"journal-article","created":{"date-parts":[[2012,8,3]],"date-time":"2012-08-03T14:13:56Z","timestamp":1344003236000},"source":"Crossref","is-referenced-by-count":24,"title":["Clinical, immunological and genetic features in eleven Algerian patients with major histocompatibility complex class II expression deficiency"],"prefix":"10.1186","volume":"8","author":[{"given":"R\u00e9da","family":"Djidjik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrine","family":"Messaoudani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azzedine","family":"Tahiat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanis","family":"Meddour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Chaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz","family":"Atek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Elmokhtar","family":"Khiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafissa Keltoum","family":"Benhalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Smati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelatif","family":"Bensenouci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mourad","family":"Baghriche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Ghaffor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,3]]},"reference":[{"issue":"1","key":"354_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1365-2249.2012.04561.x","volume":"168","author":"H Chapel","year":"2012","unstructured":"Chapel H: Classification of primary immunodeficiency diseases by the International Union of Immunological Societies (IUIS) expert committee on primary immunodeficiency 2011. Clin Exp Immunol. 2012, 168 (1): 58-59. 10.1111\/j.1365-2249.2012.04561.x.","journal-title":"Clin Exp Immunol"},{"key":"354_CR2","volume-title":"Clinical and immunological aspects of combined immunodeficiency with defective expression of HLA antigens","author":"C Griscelli","year":"1984","unstructured":"Griscelli C, Fischer A, Grospierre B, Durandy A, Bremard C, Charron D, Vilmer E, Virelizier J-L: Clinical and immunological aspects of combined immunodeficiency with defective expression of HLA antigens. 1984, Amsterdam: Excerpta Medica"},{"key":"354_CR3","first-page":"141","volume-title":"Immunodeficiencies","author":"C Griscelli","year":"1993","unstructured":"Griscelli C, Lisowska-Grospierre B, Mach B: Combined immunodeficiency with defective expression in MHC class II genes. Immunodeficiencies. Edited by: Rosen FS, Seligman M. 1993, Chur, Switzerland: Harwood Academic, 141-"},{"key":"354_CR4","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/emboj\/16.5.1045","volume":"16","author":"B Durand","year":"1997","unstructured":"Durand B, Sperisen P, Emery P: RFXAP, a novel subunit of the RFX DNA binding complex, is mutated in MHC class II deficiency. EMBO J. 1997, 16: 1045-1055. 10.1093\/emboj\/16.5.1045.","journal-title":"EMBO J"},{"key":"354_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/3081","volume":"20","author":"K Masternak","year":"1998","unstructured":"Masternak K, Barras E, Zufferey M: A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat Genet. 1998, 20: 273-277. 10.1038\/3081.","journal-title":"Nat Genet"},{"key":"354_CR6","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1101\/gad.9.9.1021","volume":"9","author":"V Steimle","year":"1995","unstructured":"Steimle V, Durand B, Barras E: A novel DNA binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 1995, 9: 1021-1032. 10.1101\/gad.9.9.1021.","journal-title":"Genes Dev"},{"key":"354_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0092-8674(05)80090-X","volume":"75","author":"V Steimle","year":"1993","unstructured":"Steimle V, Otten LA, Zufferey M, Mach B: Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell. 1993, 75: 135-146.","journal-title":"Cell"},{"key":"354_CR8","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/hmg\/7.5.879","volume":"7","author":"MC Fondaneche","year":"1998","unstructured":"Fondaneche MC, Villard J, Wiszniewski W: Genetic and molecular definition of complementation group D in MHC class II deficiency. Hum Mol Genet. 1998, 7: 879-885. 10.1093\/hmg\/7.5.879.","journal-title":"Hum Mol Genet"},{"key":"354_CR9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/0198-8859(89)90007-4","volume":"26","author":"CR Hume","year":"1989","unstructured":"Hume CR, Lee JS: Congenital immunodeficiency associated with absence of HLA class II antigens on lymphocyte result from distinct mutations in transacting factors. Hum Immunol. 1989, 26: 288-309. 10.1016\/0198-8859(89)90007-4.","journal-title":"Hum Immunol"},{"key":"354_CR10","first-page":"183","volume":"67","author":"M Krawczyk","year":"2006","unstructured":"Krawczyk M, Reith W: Regulation of MHC class II expression, a unique regulatory system identified by the study of a primary immunodeficiency disease. J Compilation. 2006, 67: 183-197.","journal-title":"J Compilation"},{"key":"354_CR11","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/hmg\/3.6.953","volume":"3","author":"B Lisowska-Grospierre","year":"1994","unstructured":"Lisowska-Grospierre B, Fondaneche MC, Rols MP: Two complementation groups accent for most cases of inherited MHC class II deficiency. Hum Mol Genet. 1994, 3: 953-958. 10.1093\/hmg\/3.6.953.","journal-title":"Hum Mol Genet"},{"key":"354_CR12","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S0092-8674(88)90389-3","volume":"53","author":"W Reith","year":"1988","unstructured":"Reith W, Satola S, Sanchez CH: Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell. 1988, 53: 897-906. 10.1016\/S0092-8674(88)90389-3.","journal-title":"Cell"},{"key":"354_CR13","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1101\/gad.14.9.1156","volume":"14","author":"K Masternak","year":"2000","unstructured":"Masternak K, Muhlethaler-Mottet A, Villard J: CIITA is a transcriptional coactivator that is recruited to MHC II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev. 2000, 14: 1156-1166.","journal-title":"Genes Dev"},{"key":"354_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1126\/science.8016643","volume":"265","author":"V Steimle","year":"1994","unstructured":"Steimle V, Siegrist CA, Mottet A: Regulation of MHC class II expression by interferon mediated by the transactivator gene CIITA. Science. 1994, 265: 106-109. 10.1126\/science.8016643.","journal-title":"Science"},{"issue":"6","key":"354_CR15","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0022-3476(05)80388-9","volume":"123","author":"C Klein","year":"1993","unstructured":"Klein C, Lisowska-Grospierre B, Ledeist F: Major histocompatibility complex class II deficiency: clinical manifestations, immunological features and outcome. J Pediatr. 1993, 123 (6): 921-928. 10.1016\/S0022-3476(05)80388-9.","journal-title":"J Pediatr"},{"issue":"19","key":"354_CR16","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1182\/blood-2011-05-352716","volume":"118","author":"M Ouederni","year":"2011","unstructured":"Ouederni M, Vincent QB, Frange P: Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients. Blood. 2011, 118 (19): 5108-5118. 10.1182\/blood-2011-05-352716.","journal-title":"Blood"},{"issue":"suppl 1","key":"354_CR17","first-page":"1","volume":"118","author":"Report of an IUIS Scientific Group","year":"1999","unstructured":"Report of an IUIS Scientific Group: Primary immunodeficiency diseases. Clin Exp Immunol. 1999, 118 (suppl 1): 1-28.","journal-title":"Clin Exp Immunol"},{"key":"354_CR18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s002510050619","volume":"51","author":"W Wiszniewski","year":"2000","unstructured":"Wiszniewski W, Fondaneche MC, Lambert N: Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II deficient patients belonging to complementation group B. Immunogenetics. 2000, 51: 261-267. 10.1007\/s002510050619.","journal-title":"Immunogenetics"},{"key":"354_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1074-7613(00)80016-3","volume":"10","author":"UM Nagarajan","year":"1999","unstructured":"Nagarajan UM, Louis-Plence P, DeSandro A: RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. Immunity. 1999, 10: 153-162. 10.1016\/S1074-7613(00)80016-3.","journal-title":"Immunity"},{"issue":"5","key":"354_CR20","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jaci.2003.07.003","volume":"112","author":"WT Shearer","year":"2003","unstructured":"Shearer WT, Rosenblatt HM, Gelman RS: Lymphocyte subsets in healthy children from birth through 18\u2009years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol. 2003, 112 (5): 973-980. 10.1016\/j.jaci.2003.07.003.","journal-title":"J Allergy Clin Immunol"},{"key":"354_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0090-1229(05)80045-5","volume":"61","author":"C Griscelli","year":"1991","unstructured":"Griscelli C: Combined immunodeficiency with defective expression in MHC class II genes. Clin Immunol Immunopathol. 1991, 61: 106-110. 10.1016\/S0090-1229(05)80045-5.","journal-title":"Clin Immunol Immunopathol"},{"key":"354_CR22","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S0929-693X(97)88145-6","volume":"4","author":"M Bejaoui","year":"1997","unstructured":"Bejaoui M, Barbouche MR, Dellagi K: Les d\u00e9ficits immunitaires primitifs en Tunisie; \u00e9tude de 152 cas. Arch Pediatr. 1997, 4: 827-831. 10.1016\/S0929-693X(97)88145-6.","journal-title":"Arch Pediatr"},{"key":"354_CR23","first-page":"435","volume":"41","author":"M Benallegue","year":"1984","unstructured":"Benallegue M, Kedjif F: Consanguinit\u00e9 et sant\u00e9 publique, \u00e9tude alg\u00e9rienne. Arch Fr P\u00e9diatr. 1984, 41: 435-440.","journal-title":"Arch Fr P\u00e9diatr"},{"key":"354_CR24","first-page":"5","volume":"18","author":"AA Bousfiha","year":"2008","unstructured":"Bousfiha AA, Ailal F, Picard C: Epid\u00e9miologie et classification des d\u00e9ficits immunitaires primitifs. Rev Mar Mal Enf. 2008, 18: 5-11.","journal-title":"Rev Mar Mal Enf"},{"key":"354_CR25","first-page":"1013","volume":"178","author":"N Lamdaouer Bouazzaoui","year":"1994","unstructured":"Lamdaouer Bouazzaoui N: Consanguinit\u00e9 et Sant\u00e9 publique au Maroc. Bull Acad Natl Med. 1994, 178: 1013-1027.","journal-title":"Bull Acad Natl Med"},{"key":"354_CR26","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.1016\/0090-1229(89)90121-9","volume":"50","author":"C Griscelli","year":"1989","unstructured":"Griscelli C, Lisowska-Grospierre B, Le Deist F: Combined immunodeficiency with abnormal expression of MHC class II genes. Clin Immunol Immunopathol. 1989, 50: S140-S148. 10.1016\/0090-1229(89)90121-9.","journal-title":"Clin Immunol Immunopathol"},{"key":"354_CR27","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0929-693X(99)80005-0","volume":"5","author":"M Bejaoui","year":"1998","unstructured":"Bejaoui M, Barbouche MR, Mellouli F: D\u00e9ficit immunitaire primitif par d\u00e9faut d\u2019expression des antig\u00e8nes de classe II: neuf observations tunisiennes. Arch Pediatr. 1998, 5: 1089-1093. 10.1016\/S0929-693X(99)80005-0.","journal-title":"Arch Pediatr"},{"key":"354_CR28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1136\/adc.83.4.356","volume":"83","author":"MA Saleem","year":"2000","unstructured":"Saleem MA, Arkwright PD, Davies EG: Clinical course of patients with major histocompatibility complex class II deficiency. Arch Dis Child. 2000, 83: 356-359. 10.1136\/adc.83.4.356.","journal-title":"Arch Dis Child"},{"key":"354_CR29","doi-asserted-by":"publisher","first-page":"5566","DOI":"10.1128\/MCB.21.16.5566-5576.2001","volume":"21","author":"N Nekrep","year":"2001","unstructured":"Nekrep N, Geyer M, Jabrane-Ferrat N, Peterlin BM: Analysis of ankyrin repeats reveals how a single point mutation in RFXANK results in bare lymphocyte syndrome. Mol Cell Biol. 2001, 21: 5566-5576. 10.1128\/MCB.21.16.5566-5576.2001.","journal-title":"Mol Cell Biol"},{"key":"354_CR30","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.4049\/jimmunol.166.9.5681","volume":"166","author":"AM Lennon-Dumenil","year":"2001","unstructured":"Lennon-Dumenil AM, Barbouche MR, Vedrenne J: Uncoordinated HLA-D gene expression in a RFXANK-defective patient with MHC class II deficiency. J Immunol. 2001, 166: 5681-5687.","journal-title":"J Immunol"},{"key":"354_CR31","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.4049\/jimmunol.164.7.3666","volume":"164","author":"UM Nagarajan","year":"2000","unstructured":"Nagarajan UM, Peijnenburg A, Gobin SJ: Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-Bdeficient cells. J Immunol. 2000, 164: 3666-3674.","journal-title":"J Immunol"},{"key":"354_CR32","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s00251-003-0609-2","volume":"55","author":"T Prod'homme","year":"2003","unstructured":"Prod'homme T, Dekel B, Barbieri G: Splicing defect in RFXANK results in a moderate combined immunodeficiency and long-duration clinical course. Immunogenetics. 2003, 55: 530-539. 10.1007\/s00251-003-0609-2.","journal-title":"Immunogenetics"},{"key":"354_CR33","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00251-002-0521-1","volume":"54","author":"W Wiszniewski","year":"2003","unstructured":"Wiszniewski W, Fondaneche MC, Louise-Plence P: Novel mutations in the RFXANK gene: RFX complex containing in vitro-generated RFXANK mutant binds the promoter without transactivating MHC II. Immunogenetics. 2003, 54: 747-755.","journal-title":"Immunogenetics"},{"key":"354_CR34","volume-title":"Eur J Pediatr","author":"H Naamane","year":"2010","unstructured":"Naamane H, El Maataoui O, Ailal F: The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population. Eur J Pediatr. 2010"},{"key":"354_CR35","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.4049\/jimmunol.167.3.1787","volume":"167","author":"W Wiszniewski","year":"2001","unstructured":"Wiszniewski W, Fondaneche MC, Le Deist F: Mutation in the class II trans-activator leading to a mild immunodeficiency. J Immunol. 2001, 167: 1787-1794.","journal-title":"J Immunol"}],"container-title":["Allergy, Asthma & Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1710-1492-8-14.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1710-1492-8-14\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1710-1492-8-14.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T14:47:13Z","timestamp":1643122033000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacijournal.biomedcentral.com\/articles\/10.1186\/1710-1492-8-14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,3]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["354"],"URL":"https:\/\/doi.org\/10.1186\/1710-1492-8-14","relation":{},"ISSN":["1710-1492"],"issn-type":[{"value":"1710-1492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,3]]},"article-number":"14"}}